tomeko

Tyrosinase-positive oculocutaneous albinism

Just diagnosed with Tyrosinase-positive oculocutaneous albinism?

You are not alone. Here is where to start: learn the basics, find a specialist or center that sees Tyrosinase-positive oculocutaneous albinism, look for clinical trials, and connect with others living with it — all in one place.

Open the full Tyrosinase-positive oculocutaneous albinism hub →

Overview

Tyrosinase-positive oculocutaneous albinism is a rare condition. Also known as OCA2. Tomeko brings together the specialists, research, clinical trials, treatments and community for Tyrosinase-positive oculocutaneous albinism so you can go from overwhelmed to oriented. For authoritative medical detail, see the reference sources below.

Identifiers: ORPHA:79432 · OMIM 203200 · ICD-10 E70.3 · GARD 0004038

Find care for Tyrosinase-positive oculocutaneous albinism

Authoritative references for Tyrosinase-positive oculocutaneous albinism

Common questions

I was just diagnosed with Tyrosinase-positive oculocutaneous albinism — what should I do first?

Start by learning the basics from an authoritative source, find a specialist or center that sees Tyrosinase-positive oculocutaneous albinism, and connect with a patient organization. Tomeko brings these together on one hub.

Where can I find a specialist for Tyrosinase-positive oculocutaneous albinism?

Use Tomeko's specialist and Centers-of-Excellence directories to find clinicians who treat Tyrosinase-positive oculocutaneous albinism, filtered to your area.

Are there clinical trials for Tyrosinase-positive oculocutaneous albinism?

Tomeko shows live, recruiting studies for Tyrosinase-positive oculocutaneous albinism from ClinicalTrials.gov on the hub.

Informational only — not medical advice. Always consult a qualified clinician. Provider and reference data from public sources (NIH GARD, Orphanet, OMIM, HPO, MONDO, ClinicalTrials.gov, CMS NPPES). © Tomeko · tomekohealth.com